Solution to One Prop. 71 Flaw
By Jesse Reynolds,
Los Angeles Times
| 12. 17. 2007
A Letter to the Editor
Re "Stem cell housecleaning," editorial, Dec. 12
Your editorial appropriately highlights fundamental flaws of Proposition 71, the initiative that created the state's $3-billion stem cell research agency. Its governing board is stacked with representatives of the very institutions seeking to maximize their share of the public funding pie -- an inherent conflict of interest. The latest scandal, in which a board member tried to influence a grant to his home institution, is just a symptom of the structural flaws that were built into the program. It's time for the Legislature to step in and reform it.
But that's just part of the problem. Board chair and Proposition 71 author Robert Klein has consistently worked against accountability and transparency. He has misled the public and has been dismissive of the Legislature. Through activities such as heading up his own private stem cell research lobbying group while continuing his role as board chair, he's crossed the line of appropriate behavior for a public servant. He's had three years to demonstrate otherwise. It's time for him to go.
Jesse Reynolds
Oakland
The writer...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...